$0.91 0.00 (%) Cesca Therapeutics Inc - NASDAQ

Feb. 27, 2015 | 04:00 PM

Partner Headlines

  1. US Stock Futures Surge Ahead Of Manufacturing Data

    Benzinga | Jan. 2, 2015 | 07:00AM EST
  2. UPDATE: Cesca Receives Feedback From the FDA on Its Pivotal Investigational Device Exemption ("IDE") Application for Treating Critical

    Benzinga | Jan. 2, 2015 | 06:01AM EST
  3. US Stock Futures Drop Ahead Of Economic Data

    Benzinga | Nov. 20, 2014 | 07:38AM EST
  4. Cesca Therapeutics Announces Change In Executive Leadership

    Benzinga | Oct. 29, 2014 | 09:00AM EST
  5. Earnings Scheduled For September 25, 2014

    Benzinga | Sep. 25, 2014 | 06:23AM EST
  6. Morning Market Losers

    Benzinga | Jun. 13, 2014 | 09:44AM EST
  7. Morning Market Movers

    Benzinga | Jan. 22, 2014 | 10:22AM EST
  8. Morning Market Movers

    Benzinga | Jan. 21, 2014 | 10:30AM EST
  9. ThermoGenesis Announces Sale of Thermoline Product Line to Helmer Scientific

    Benzinga | Jan. 3, 2013 | 02:03AM EST
  10. THERMOGENESIS Corp. Reports Operating Results (10-Q)

    GuruFocus | Nov. 13, 2012 | 11:06AM EST
  11. Earnings Scheduled For September 20, 2012

    Benzinga | Sep. 19, 2012 | 20:03PM EST
  12. ThermoGenesis Receives $2M Cash Payment from Product Line Transaction

    Benzinga | Aug. 22, 2012 | 05:51AM EST
  13. ThermoGenesis Announces Completion of CryoSeal Product Line Transaction With Asahi

    Benzinga | Aug. 22, 2012 | 05:48AM EST
  14. Camelot Information Systems, ThermoGenesis Gapping Up Monday

    FoxBusiness | Aug. 20, 2012 | 04:30AM EST
  15. THERMOGENESIS Corp. Reports Operating Results (10-Q)

    GuruFocus | Feb. 10, 2012 | 00:49AM EST
  16. Thermogenesis Signs Worldwide Res-Q System Distribution Agreement With Arthrex for Sports Medicine Applications

    Benzinga | Jan. 10, 2012 | 05:41AM EST
  17. ThermoGenesis Announces Approval of AXP by India Ministry of Health

    Benzinga | Jan. 4, 2012 | 06:42AM EST
Trading Center